Tradestie Institutional Equity Comparison Engine

NMR vs KB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KB Overall Edge

KB Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to KB Financial Group Inc (KB) driven by superior Valuation, Growth & Margin, Momentum & Technical while NMR counters with relative strength in Options & Structure. Fundamentally, NMR trades at 12.7x Forward P/E with 25.1% operating margin (+17.9% YoY revenue) versus KB at 0.0x Forward P/E and 26.2% operating margin (+514.4% YoY). In options structure, NMR sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against KB sits in UNCLASSIFIED (7th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner KB
NMR 12.7x vs KB 0.0x Fwd P/E
Growth & Margin Winner KB
Op Margin 25.1% vs 26.2% ยท YoY +17.9% vs +514.4%
Momentum & Technical Winner KB
1Y +26.3% vs +30.0% ยท 52W Pos 60% vs 66%
Options & Structure Winner NMR
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (7th %ile IV)
NMR NYSE
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap $28.3B
1M Return +2.36%
1Y Return +26.32%
Forward P/E 12.7x
Unified AI Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
KB NYSE
KB Financial Group Inc
Commercial Banks, Nec
$115.77
-1.65% 1D
Market Cap $40.8B
1M Return -2.83%
1Y Return +30.03%
Forward P/E 0.0x
Unified AI Score
54.3 / 100 HOLD
Tech 49.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NMR +26.32% KB +30.03% Spread: +3.71 pp (KB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NMR TTM Op. Margin: 25.1% KB TTM Op. Margin: 26.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs KB. Trailing 12-month operating profitability (NMR 25.1% vs KB 26.2%) and valuation multiples (NMR 12.7x vs KB 0.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NMR (2) vs KB (7)
Institutional Metric NMR KB Criterion Row Winner
Market Capitalization Scale $28.3B $40.8B Larger Scale KB
Trailing P/E Ratio Valuation 11.2x 10.1x Lower Multiple KB
Forward P/E Ratio Valuation 12.7x 0.0x Lower Multiple KB
Revenue Growth (YoY) Growth +17.9% +514.4% Higher Growth KB
Operating Margin (TTM) Profitability 25.1% 26.2% Higher Margin KB
Net Profit Margin Profitability 17.1% 17.2% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency 11.5% 10.2% Higher ROE NMR
52-Week Range Position Momentum 60% ($7โ€“$11) 66% ($81โ€“$133) Stronger Trend KB
Beta / 30D Volatility Risk Regime 1.03ฮฒ ยท 29% Vol 1.33ฮฒ ยท 29% Vol Lower Realized Risk NMR
Unified Institutional Score Composite Signal 44.5 / 100 (HOLD) 54.3 / 100 (HOLD) Higher Composite KB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NMR vs KB Buy Guide
NMR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live NMR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
KB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live KB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NMR nor KB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.